Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-39929

Doberstein, K; Schramme, A; Lee, S B; Blaheta, R A; Wedel, S; Moch, H; Schraml, P; Pfeilschifter, J; Kristiansen, G; Gutwein, P (2011). L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells. Carcinogenesis, 32(3):262-270.

[img]Accepted Version
PDF - Registered users only
2MB

View at publisher
[img] PDF - Registered users only
2MB

Abstract

Conflicting data exist about the expression of L1 cell adhesion molecule (L1-CAM) in clear cell renal cell carcinoma (ccRCC). To determine the clinical usefullness of L1-CAM as a therapeutic or prognostic marker molecule in renal cancer patients, we analyzed its expression on a cohort of 282 RCC patients. L1-CAM expression was found in 49.5 % of 282 renal cancer tissues. Importantly, L1-CAM expression in patients with ccRCC was associated with significantly shorter patient survival time. We further present evidence that L1-CAM was involved in the resistance against therapeutic reagents like rapamycin, sunitinib and cisplatin. The downregulation of L1-CAM expression decreased renal cancer cell proliferation and reduced the expression of cyclin D1. In addition, we found out that VHL deficiency was accompanied by a downregulation of the transcription factor PAX8 and L1-CAM. In normal renal tissue, PAX8 and L1-CAM were co-expressed in collecting duct cells. Importantly, the downregulation of PAX8 by siRNA increased the expression of L1-CAM and concomitantly induced the migration of renal cancer cells. Furthermore we observed in 65.3 % of 282 RCC patients a downregulation of PAX8 expression. With chromatin immunoprecipitation analysis we additionally demonstrate that PAX8 can bind to the promotor of L1-CAM and we further observed that the downregulation of PAX8 was accompanied by increased L1-CAM expression in a high fraction of ccRCC patients. In summary we show that VHL and PAX8 are involved in the regulation of L1-CAM in renal cancer and L1-CAM represents an important therapeutic and prognostic marker protein for the treatment of ccRCC.

Citations

12 citations in Web of Science®
15 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

2 downloads since deposited on 13 Jan 2011
0 downloads since 12 months

Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Surgical Pathology
DDC:610 Medicine & health
Language:English
Date:2011
Deposited On:13 Jan 2011 12:48
Last Modified:27 Nov 2013 17:36
Publisher:Oxford University Press
ISSN:0143-3334
Publisher DOI:10.1093/carcin/bgq249
PubMed ID:21097529

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page